What is Novavax's PP&E (net)?

Novavax (NVAX) reported PP&E (net) of $42.15M in Q1 2026.

How has Novavax's PP&E (net) changed year-over-year?

Novavax's PP&E (net) decreased by 68.4% year-over-year, from $133.54M to $42.15M.

What is the long-term trend for Novavax's PP&E (net)?

Over 5 years (2020 to 2025), Novavax's PP&E (net) has grown at a -24.3% compound annual growth rate (CAGR), from $179.95M to $44.8M.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Novavax NVAX PP&E (Net)

PP&E (Net) at other companies

ModernaMRNA

$2.09B-5.7%

Roivant SciencesROIV

$11.99M-0.6%

Merck & Co.MRK

$25.43B+2.6%

Vaxcyte, Inc.PCVX

$260.7M+20.1%

Viridian Therapeutics, Inc.VRDN

$1.13M-2.8%

ALN

Alnylam PharmaceuticalsALNY

$518.26M+3.9%

Segments

By geography

See full

United States$60.68M—

Other financials

Income statement

See full

Revenue$139.5M-79.1%

Gross profit$108.8M-83.3%

Operating income-$15.4M-103%

Net income-$9.5M-102%

EPS (diluted)-$0.06-102%

Balance sheet

See full

Cash & equivalents$228.4M-13.3%

Total debt$295.1M+404%

Total equity-$144.8M-91.4%

Total assets$1.0B-19.3%

Cash flow

See full

Operating cash flow-$32.4M+82.5%

CapEx$1.3M-20.4%

Free cash flow-$33.7M+82.0%

Valuation

See full

Market cap$1.46B+41.0%

Enterprise value$1.53B+83.6%

P/S2.5×+1.6×

Profitability

See full

Gross margin85%-2.5pp

Operating margin-13.1%-45.9pp

Net margin-14.7%-52.9pp

FCF margin-58.9%-61.4pp

Returns & leverage

See full

Return on equity-238.6%—

Debt / equity1.5×—

Current ratio2.5×+0.4×

Where this comes from

Reported directly by Novavax in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Novavax’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Novavax's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Novavax's PP&E (net)?: Novavax (NVAX) reported PP&E (net) of $42.15M in Q1 2026.
How has Novavax's PP&E (net) changed year-over-year?: Novavax's PP&E (net) decreased by 68.4% year-over-year, from $133.54M to $42.15M.
What is the long-term trend for Novavax's PP&E (net)?: Over 5 years (2020 to 2025), Novavax's PP&E (net) has grown at a -24.3% compound annual growth rate (CAGR), from $179.95M to $44.8M.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.